LIVE FROM THE DATABASETRANSACTIONS 387,078COMPANIES 5,891LATEST TRADE Oct 16UPDATED Oct 17, 07:14 PM
Trading dayFriday

January 17, 2025

115 transactions from 74 filings, by 73 insiders across 44 companies. This is the date the trade happened, not the date it was filed — a filing may report a trade from days earlier.

Transactions
1156 P · 58 S
Bought · P
$405Kopen market
Sold · S
$10.1Mopen market
Net
−$9.7Mnet selling

Every open-market trade

All purchases and sales reported for this day, largest first.

CompanyTickerInsiderDateCodeSharesPriceValueHeld after
AGILYSYS INCAGYSKaufman 2012 Descendants Trust, David N. Smith, TrusteeOtherJan 17SPLAN7,500$128.17$961K255,576
Atlassian CorpTEAMFarquhar ScottDirJan 17SPLAN3,044$252.14$768K394,356
Atlassian CorpTEAMCannon-Brookes MichaelCEOJan 17SPLAN3,044$252.14$768K389,452
Atlassian CorpTEAMFarquhar ScottDirJan 17SPLAN2,898$253.05$733K389,552
Atlassian CorpTEAMCannon-Brookes MichaelCEOJan 17SPLAN2,897$253.05$733K392,496
Accenture plcACNSweet Julie SpellmanCEOJan 17SPLAN1,402$354.10$496K29,961
Atlassian CorpTEAMCannon-Brookes MichaelCEOJan 17SPLAN1,757$254.00$446K395,393
Atlassian CorpTEAMFarquhar ScottDirJan 17SPLAN1,756$254.00$446K392,450
Atlassian CorpTEAMBHARADWAJ ANUTTHARAPresJan 17SPLAN1,520$259.85$395K210,471
Dorman Products, Inc.DORMBERMAN STEVEN LDirJan 17SPLAN2,775$131.22$364K823,147
Accenture plcACNSweet Julie SpellmanCEOJan 17SPLAN1,017$354.91$361K28,944
AAR CORPAIRHolmes John McClain IIICEOJan 17S5,000$70.81$354K341,680
Accenture plcACNSharma ManishCEOJan 17SPLAN868$354.16$307K6,587
1 800 FLOWERS COM INCFLWSFund 1 Investments, LLC10%JOINTJan 17P37,000$8.15$302K4,579,364
Atlas Energy Solutions Inc.AESILeveille Brian Anthony10%Jan 17S10,000$25.00$250K387,010
Accenture plcACNSharma ManishCEOJan 17SPLAN689$355.04$245K5,898
Accenture plcACNBeatty AngelaChiefJan 17SPLAN647$354.20$229K5,798
Accenture plcACNMacchi MauroCEOJan 17SPLAN570$354.73$202K4,974
Apellis Pharmaceuticals, Inc.APLSFrancois CedricCEOJan 17S6,007$29.96$180K301,408
Applied Digital Corp.APLDNottenburg Richard NDirJan 17S20,000$8.85$177K342,923
TRIMBLE INC.TRMBAllison JenniferGCJan 17SPLAN2,314$74.74$173K4,414
Accenture plcACNPark Angie YCFOJan 17SPLAN438$354.04$155K8,921
Accenture plcACNMacchi MauroCEOJan 17SPLAN430$353.78$152K5,544
BECTON DICKINSON & COBDXGarrison Michael DavidPresJan 17SPLAN597$236.51$141K5,544
Accenture plcACNBeatty AngelaChiefJan 17SPLAN314$355.01$111K5,484
TRIMBLE INC.TRMBAllison JenniferGCJan 17SPLAN1,257$74.77$94K3,157
Sky Harbour Group CorpSKYHBOSTON OMAHA Corp10%Jan 17S7,861$11.36$89K10,820,950
Accenture plcACNPark Angie YCFOJan 17SPLAN214$354.85$76K8,707
374Water Inc.SCWONagar Yaacov10%Jan 17S114,998$0.60$69K36,861,882
Apellis Pharmaceuticals, Inc.APLSWatson David O.GCJan 17S2,201$29.96$66K105,555
Apellis Pharmaceuticals, Inc.APLSTownsend Adam J.ChiefJan 17S2,201$29.96$66K88,068
Apellis Pharmaceuticals, Inc.APLSNicholson NurChiefJan 17S2,145$29.96$64K52,011
Apellis Pharmaceuticals, Inc.APLSBaumal CarolineCMOJan 17S1,853$29.96$56K53,707
Apellis Pharmaceuticals, Inc.APLSSullivan Timothy EugeneCFOJan 17S1,730$29.96$52K86,370
Atlassian CorpTEAMFarquhar ScottDirJan 17SPLAN150$254.85$38K394,206
Atlassian CorpTEAMCannon-Brookes MichaelCEOJan 17SPLAN150$254.85$38K397,150
Apellis Pharmaceuticals, Inc.APLSLewis KarenChiefJan 17S1,241$29.96$37K43,858
Apellis Pharmaceuticals, Inc.APLSDeLong Mark JeffreyChiefJan 17S1,235$29.96$37K57,561
Arena Group Holdings, Inc.ARENPetzel ChristopherDirJan 17S25,000$1.23$31K25,010
Arena Group Holdings, Inc.ARENRandall CavittDirJan 17P25,000$1.23$31K210,168
Accenture plcACNSweet Julie SpellmanCEOJan 17SPLAN78$355.84$28K28,866
Atlassian CorpTEAMFarquhar ScottDirJan 17SPLAN100$258.43$26K389,452
Atlassian CorpTEAMCannon-Brookes MichaelCEOJan 17SPLAN100$258.43$26K397,300
Anixa Biosciences IncANIXTitterton Lewis H jrDirJan 17P10,000$2.57$26K922,334
Apellis Pharmaceuticals, Inc.APLSDeschatelets PascalChiefJan 17S750$29.96$22K1,137,445
Apellis Pharmaceuticals, Inc.APLSChopas James GeorgeCAOJan 17S715$29.96$21K36,643
NUVEEN NEW YORK QUALITY MUNICIPAL INCOME FUNDNANBANK OF AMERICA CORP /DE/10%JOINTJan 17P1,611$11.37$18K1,611
Adaptimmune Therapeutics PLCADAPRawcliffe AdrianCEOJan 17S30,601$0.58$18K44,327
BARNWELL INDUSTRIES INCBRNHopkins Craig DouglasCEOJan 17P10,000$1.65$17K151,000
American Strategic Investment Co.NYCSCHORSCH NICHOLAS S10%JOINTJan 17P1,367$9.21$13K939,187
Accenture plcACNPark Angie YCFOJan 17SPLAN33$355.90$12K8,674
NUVEEN NEW YORK QUALITY MUNICIPAL INCOME FUNDNANBANK OF AMERICA CORP /DE/10%JOINTJan 17S500$11.24$6K1,011
NUVEEN NEW YORK QUALITY MUNICIPAL INCOME FUNDNANBANK OF AMERICA CORP /DE/10%JOINTJan 17S400$11.24$4K511
NUVEEN NEW YORK QUALITY MUNICIPAL INCOME FUNDNANBANK OF AMERICA CORP /DE/10%JOINTJan 17S304$11.24$3K100
Adaptimmune Therapeutics PLCADAPNorry ElliotCMOJan 17S5,584$0.58$3K7,510
Adaptimmune Therapeutics PLCADAPLunger JohnChiefJan 17S5,584$0.58$3K7,510
Adaptimmune Therapeutics PLCADAPBertrand William C JRCOOJan 17S5,584$0.58$3K7,510
Accolade, Inc.ACCDSINGH RAJEEVCEOJan 17S309$6.86$2K820,211
Accolade, Inc.ACCDCavanaugh Robert NPresJan 17S186$6.86$1K215,089
NUVEEN NEW YORK QUALITY MUNICIPAL INCOME FUNDNANBANK OF AMERICA CORP /DE/10%JOINTJan 17S107$11.23$1K404
NUVEEN NEW YORK QUALITY MUNICIPAL INCOME FUNDNANBANK OF AMERICA CORP /DE/10%JOINTJan 17S100$11.25$1K1,511
NUVEEN NEW YORK QUALITY MUNICIPAL INCOME FUNDNANBANK OF AMERICA CORP /DE/10%JOINTJan 17S100$11.24$1K0
NUVEEN NEW YORK QUALITY MUNICIPAL INCOME FUNDNANBANK OF AMERICA CORP /DE/10%JOINTJan 17S100$11.24$1K911
Accolade, Inc.ACCDBarnes Stephen H.CFOJan 17S154$6.86$1K222,244
showing 64 of 64 open-market tradesJanuary 17, 2025

The rest of the day

The other 51 transactions are administrative: awards, option exercises, shares withheld for tax. They are not trades on the open market and have no purchase price, which is why they carry no amount and are left out of the totals above.

CodeWhat it meansCount
AAward — grant under a compensation or incentive plan17
MOption exercise — acquisition through exercise of a derivative10
GGift of securities, given or received8
FTax withholding — shares withheld by the issuer for the exercise price or taxes5
JOther acquisition or disposition — see the filing footnotes4
XExercise of an in-the-money or at-the-money derivative4
DDisposition of securities back to the issuer2
LSmall acquisition under Rule 16a-61